Ravinder Earla
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Glaucoma and retinal disorders 3
-
- Nicotinic Acetylcholine Receptors Study 3
- Co-authors
- Ashim K. Mitra (6 shared papers)Dhananjay Pal (5 shared papers)Ashim K. Mitra (5 shared papers)Sriram Gunda (4 shared papers)Kishore Cholkar (5 shared papers)Sai H. S. Boddu (4 shared papers)Santosh Kumar (5 shared papers)Anil Kumar (4 shared papers)
- Journals
- International Journal of Pharmaceutics (2 papers)Drug Metabolism and Disposition (2 papers)AAPS PharmSciTech (1 paper)Current Eye Research (1 paper)Bioanalysis (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Ravinder Earla
18 papers receiving 503 citations
Peers
Comparison fields: 5 of 76
- Pharmaceutical Science 137
- Virology 58
- Biological Psychiatry 25
- Ophthalmology 88
- Pharmacology 32
Countries citing papers authored by Ravinder Earla
This map shows the geographic impact of Ravinder Earla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravinder Earla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravinder Earla more than expected).
Fields of papers citing papers by Ravinder Earla
This network shows the impact of papers produced by Ravinder Earla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravinder Earla. The network helps show where Ravinder Earla may publish in the future.
Co-authors
The 25 scholars most cited alongside Ravinder Earla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 87 | |
| 2 | 2011 | 49 | |
| 3 | 2009 | 44 | |
| 4 | 2010 | 43 | |
| 5 | 2013 | 42 | |
| 6 | 2012 | 41 | |
| 7 | 2010 | 37 | |
| 8 | 2010 | 31 | |
| 9 | 2012 | 28 | |
| 10 | 2013 | 26 | |
| 11 | 2010 | 25 | |
| 12 | 2011 | 20 | |
| 13 | 2012 | 19 | |
| 14 | 2014 | 10 | |
| 15 | 2024 | 7 | |
| 16 | 2014 | 3 | |
| 17 | 2016 | 3 | |
| 18 | Development and Evaluation of Dexamethasone Prodrugs for the Treatment of Ocular Ailments | 2009 | 1 |
About Ravinder Earla
Ravinder Earla is a scholar working on Ophthalmology, Molecular Biology, Epidemiology, Infectious Diseases and Pharmacology, having authored 18 papers that have together received 516 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers), HIV/AIDS drug development and treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Herpesvirus Infections and Treatments (3 papers), Smoking Behavior and Cessation (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Pharmaceutical Science (137 citations), Virology (58 citations), Biological Psychiatry (25 citations), Ophthalmology (88 citations) and Pharmacology (32 citations). Ravinder Earla has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Ashim K. Mitra, Dhananjay Pal, Ashim K. Mitra, Sriram Gunda, Kishore Cholkar, Sai H. S. Boddu, Santosh Kumar, Anil Kumar, Mengyao Jin and Pradeep K. Karla. Their work appears in journals such as International Journal of Pharmaceutics, Drug Metabolism and Disposition, AAPS PharmSciTech, Current Eye Research and Bioanalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.